Concord Drugs Ltd
₹68.00▼ -0.40 (-0.58%)
CONCORD·BSE·Healthcare
Market Cap
89.59 Cr
PE Ratio
200.00
Volume
2,775
Day High - Low
69.00 - 66.50
52W High-Low
92.52 - 64.00
₹68.00▼ -0.40 (-0.58%)
Market Cap89.59 Cr
PE Ratio200.00
Volume2,775
Day High - Low69.00 - 66.50
52W High-Low92.52 - 64.00
Concord Drugs Ltd (CONCORD): company summary
The company's annual revenue grew 0.7% to ₹45 crore, but annual net profit remained at ₹0 crore, with a net profit margin declining to 0.7% from 1.1%.
Concord Drugs Ltd (CONCORD) is a micro-cap Healthcare company valued at ₹90 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Concord Drugs Ltd last traded at ₹68, modestly down 0.58% on the day.
- Financial performance
- The company's annual revenue grew 0.7% to ₹45 crore, but annual net profit remained at ₹0 crore, with a net profit margin declining to 0.7% from 1.1%. The latest quarter saw revenue rise 53.9% to ₹21 crore and net profit surge 825.0% to ₹1 crore compared to the same quarter a year earlier.
- Valuation multiples
- The stock trades at 200.0 times earnings, a premium to the Healthcare median of 32.0, 2.06 times book value.
- Things to watch
- The company reported an annual net profit of ₹0 crore, down 27.7% year-over-year. The net profit margin fell 0.3 percentage points to 0.7%. The stock is 26.1% below its 52-week high. The company's revenue growth over the past three years has been negative at -54.8% annually.
- Where it stands
- The company's latest quarter net profit rose 825.0% to ₹1 crore, while annual net profit remained at ₹0 crore. The stock is 26.1% below its 52-week high, and the net profit margin fell to 0.7%.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
1.0/10
Poor
Fair Value
Sign in to see
ROE
0.99%
Weak
P/E
200.00x
Expensive
Debt / Equity
0.50
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Poor
Price performance
Day₹66.50
₹69.00
52W₹64.00
₹92.52
DocStoX take
Held back by momentum (0.0).
DocStoX score
Low confidence1.0
/10
Poor
Quality
Modest
ROE 1.0%
Valuation
Expensive
P/E 200.0×
Growth
Flat
Revenue -33.8% 5Y CAGR
Risk
Moderate
D/E 0.50
Momentum
Weak
14% of 52-week range
At a glance
Market Cap
₹90 Cr
52W High / Low
₹93 / ₹64
Dividend Yield
—
Promoter Holding
45.08%
EPS (TTM)
₹0.34
Book Value
₹34.11
Key highlights
- Profitable in all of the last 5 years
- Profit shrinking 66% a year
- Revenue shrinking 34% a year
1 Positive4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Concord Drugs Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Concord Drugs Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LLAURUS LABS LIMITEDZYDUS LIFESCIENCES LTDAPOLLO HOSPITALS ENTER. LCIPLA LTDDR. REDDY S LABORATORIESAUROBINDO PHARMA LTDMANKIND PHARMA LIMITEDLUPIN LIMITEDMANIPAL HEALTH ENTERPRI L
Compare Concord Drugs Ltd with peers
Related tools & concepts
Value Concord Drugs Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing